Nordic Cell Therapy Group Holding ApS

CVR 46007441 · Private limited company (ApS) · Active · Very high risk

Nordic Cell Therapy Group Holding ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 11.5% over the next 12 months, which is 8.2 times the average for Danish companies. CEO: Juan Carlos Villaescusa Ramirez, Michael Wagner Christiansen.

Bankruptcy risk for Nordic Cell Therapy Group Holding ApS

11.5%
probability of bankruptcy within 12 months
Very high risk

8.2 × the average (1.41%) · higher risk than 97% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO changes in the last year1 · bankruptcy rate 21.1%2.4×
Published annual reports0 · bankruptcy rate 16.7%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Age (years)< 1 yrs · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO< 0.5 yrs · bankruptcy rate 11.6%1.3×

Reduces the risk

Number of CEOs2 · bankruptcy rate 5.7%0.65×
Industry changes1 · bankruptcy rate 6.5%0.74×
Moves in the last 2 years0 · bankruptcy rate 7.4%0.84×
Registered owners2 · bankruptcy rate 7.6%0.87×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
46007441
Status
Active
Company type
Private limited company (ApS)
Founded
(0 years)
Address
c/o Juan Carlos Villaescusa Ramirez, Strandlodsvej 23C, 2. mf
2300 København S
Municipality
København
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 20k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 0
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address33
Going-concern uncertaintyNo

Management, owners and auditor

RoleNameFromTo
CEOJuan Carlos Villaescusa RamirezCurrent
CEOMichael Wagner ChristiansenCurrent
Owner (50%)Juan Carlos Villaescusa RamirezCurrent
Owner (33%)Michael Wagner ChristiansenCurrent
FounderJuan Carlos Villaescusa RamirezCurrent
FounderMichael Wagner ChristiansenCurrent

The CEOs' other companies

Juan Carlos Villaescusa Ramirez – 2 other companies

Michael Wagner Christiansen – 2 other companies

Address history (0 moves)

c/o Juan Carlos Villaescusa Ramirez, Strandlodsvej 23C, 2. mf, 2300 København S

Former names

Nordic Cell Therapy Group Holding ApS – now
Nordic Cell Therapy Group ApS –

Other companies at the same address

Similar companies in København

Questions and answers about Nordic Cell Therapy Group Holding ApS

Has Nordic Cell Therapy Group Holding ApS gone bankrupt?

No, Nordic Cell Therapy Group Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Nordic Cell Therapy Group Holding ApS?

Our model estimates a bankruptcy risk of 11.5% over the next 12 months (very high risk), which is 8.2 times the average for Danish companies.

Who is the CEO of Nordic Cell Therapy Group Holding ApS?

Juan Carlos Villaescusa Ramirez, Michael Wagner Christiansen are the CEOs of Nordic Cell Therapy Group Holding ApS.

When was Nordic Cell Therapy Group Holding ApS founded?

Nordic Cell Therapy Group Holding ApS was founded on 4 November 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.